254
Participants
Start Date
December 31, 2010
Primary Completion Date
October 31, 2012
Study Completion Date
October 31, 2012
Xiapex
Xiapex 0.58 mg in diluent, 0.25 ml for MP joints and 0.20 ml for PIP joints, injection to cord over joint using either 26 or 27 gauge needle, maximum 3 injections with 30 days interval between injections to any single site, maximum 5 injections in this protocol
Pfizer Investigational Site, Miskolc
Pfizer Investigational Site, Silkeborg
Pfizer Investigational Site, Berlin
Pfizer Investigational Site, Savona
Pfizer Investigational Site, Sesto San Giovanni
Pfizer Investigational Site, Málaga
Pfizer Investigational Site, Montpellier
Pfizer Investigational Site, Modena
Pfizer Investigational Site, Münster
Pfizer Investigational Site, Bonn
Pfizer Investigational Site, Tübingen
Pfizer Investigational Site, Paris
Pfizer Investigational Site, Nuremberg
Pfizer Investigational Site, Bad Neustadt an der Saale
Pfizer Investigational Site, Copenhagen
Pfizer Investigational Site, Nice
Pfizer Investigational Site, Paris
Pfizer Investigational Site, Elche
Pfizer Investigational Site, L'Hospitalet de Llobregat
Pfizer Investigational Site, Barcelona
Pfizer Investigational Site, Barcelona
Pfizer Investigational Site, Malmo
Pfizer Investigational Site, Stockholm
Pfizer Investigational Site, Uppsala
Pfizer Investigational Site, Derby
Pfizer Investigational Site, Glasgow
Pfizer Investigational Site, Norwich
Pfizer Investigational Site, Southampton
Lead Sponsor
Pfizer
INDUSTRY